logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Reynolds, Kelly
    Born in June 1986
    Individual (3 offsprings)
    Officer
    icon of calendar 2020-01-14 ~ now
    OF - Director → CIF 0
    Kelly Reynolds
    Born in June 1986
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2020-01-14 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Fitzsimons, Morgan
    Born in February 1985
    Individual (4 offsprings)
    Officer
    icon of calendar 2020-09-17 ~ now
    OF - Director → CIF 0
  • 3
    Cox, Chantal
    Born in September 1991
    Individual (1 offspring)
    Officer
    icon of calendar 2023-03-03 ~ now
    OF - Director → CIF 0
Ceased 4
  • 1
    Reynolds, Guy David
    Ceo born in March 1982
    Individual (9 offsprings)
    Officer
    icon of calendar 2020-09-08 ~ 2023-03-03
    OF - Director → CIF 0
  • 2
    Gibbs, Will
    Fund Manager born in August 1989
    Individual
    Officer
    icon of calendar 2024-06-28 ~ 2025-05-21
    OF - Director → CIF 0
  • 3
    Zeidler, Phil
    Non Executive born in September 1968
    Individual (7 offsprings)
    Officer
    icon of calendar 2024-05-01 ~ 2025-05-14
    OF - Director → CIF 0
  • 4
    Schmid, Peter
    Professor Of Cancer Medicine born in August 1971
    Individual (1 offspring)
    Officer
    icon of calendar 2020-10-09 ~ 2023-03-03
    OF - Director → CIF 0
parent relation
Company in focus

PERCI HEALTH LTD

Previous name
RESILI LTD - 2020-12-09
Standard Industrial Classification
62090 - Other Information Technology Service Activities
Brief company account
Average Number of Employees
202024-01-01 ~ 2024-12-31
172023-02-01 ~ 2023-12-31
Intangible Assets
99,437 GBP2024-12-31
107,437 GBP2023-12-31
Fixed Assets
99,437 GBP2024-12-31
107,437 GBP2023-12-31
Debtors
Current
1,038,584 GBP2024-12-31
806,921 GBP2023-12-31
Cash at bank and in hand
348,487 GBP2024-12-31
1,341,892 GBP2023-12-31
Current Assets
1,387,071 GBP2024-12-31
2,148,813 GBP2023-12-31
Net Current Assets/Liabilities
1,202,117 GBP2024-12-31
1,959,152 GBP2023-12-31
Total Assets Less Current Liabilities
1,301,554 GBP2024-12-31
2,066,589 GBP2023-12-31
Net Assets/Liabilities
1,301,554 GBP2024-12-31
2,066,589 GBP2023-12-31
Equity
Called up share capital
3 GBP2024-12-31
3 GBP2023-12-31
Share premium
5,504,056 GBP2024-12-31
5,210,549 GBP2023-12-31
Retained earnings (accumulated losses)
-4,202,505 GBP2024-12-31
-3,143,963 GBP2023-12-31
Equity
1,301,554 GBP2024-12-31
2,066,589 GBP2023-12-31
Intangible Assets - Gross Cost
Development expenditure
154,237 GBP2024-12-31
147,437 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
54,800 GBP2024-12-31
40,000 GBP2023-12-31
Intangible Assets
Development expenditure
99,437 GBP2024-12-31
107,437 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
86,573 GBP2024-12-31
98,150 GBP2023-12-31
Other Debtors
Current
4,784 GBP2024-12-31
3,170 GBP2023-12-31
Prepayments/Accrued Income
Current
17,666 GBP2024-12-31
21,918 GBP2023-12-31
Debtors - Deferred Tax Asset
Current
929,561 GBP2024-12-31
683,683 GBP2023-12-31
Bank Overdrafts
-574 GBP2024-12-31
-2,755 GBP2023-12-31
Cash and Cash Equivalents
347,913 GBP2024-12-31
1,339,137 GBP2023-12-31
Bank Overdrafts
Current
574 GBP2024-12-31
2,755 GBP2023-12-31
Trade Creditors/Trade Payables
Current
106,806 GBP2024-12-31
69,666 GBP2023-12-31
Taxation/Social Security Payable
Current
9,271 GBP2024-12-31
50,685 GBP2023-12-31
Other Creditors
Current
2,588 GBP2024-12-31
5,795 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
65,715 GBP2024-12-31
60,760 GBP2023-12-31
Creditors
Current
184,954 GBP2024-12-31
189,661 GBP2023-12-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
929,561 GBP2024-01-01 ~ 2024-12-31
Net Deferred Tax Liability/Asset
929,561 GBP2024-12-31
683,683 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2,203,990 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.0000012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
672,127 shares2024-12-31
581,420 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.0000012024-01-01 ~ 2024-12-31

  • PERCI HEALTH LTD
    Info
    RESILI LTD - 2020-12-09
    Registered number 12402935
    icon of address1 Vincent Square, London, London SW1P 2PN
    PRIVATE LIMITED COMPANY incorporated on 2020-01-14 (6 years). The company status is Active.
    The last date of confirmation statement was made at 2025-01-13
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.